(Q44638919)

English

In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

pharmaceutical science

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

author name string

Susanne Bredenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Margareta Duberg

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bo Lennernäs

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hans Lennernäs

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Anders Pettersson

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Marie Westerberg

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Christer Nyström

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0928098703002215?httpAccept=text/xml

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

https://api.elsevier.com/content/article/PII:S0928098703002215?httpAccept=text/plain

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

European Journal of Pharmaceutical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

327-334

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

In-vitro evaluation of bioadhesion in particulate systems and possible improvement using interactive mixtures

4

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

A New Tablet Disintegrating Agent: Cross-Linked Polyvinylpyrrolidone

14

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery

17

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Evaluation of critical binder properties affecting the compactibility of binary mixtures

18

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Intravenous fentanyl kinetics.

20

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA

22

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Studies on direct compression of tablets. I. The effect of particle size in mixing finely divided powders with granules

24

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

The use of ordered mixtures for improving the dissolution rate of low solubility compounds

25

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Dissolution rate measurements of sparingly soluble compounds with the Coulter Counter model TAII.

27

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Breakthrough pain: definition, prevalence and characteristics

28

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Management of cancer pain

29

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil

30

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate

32

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.

33

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug

34

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Sublingual absorption of selected opioid analgesics

36

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study

41

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

42

1 reference

10.1016/J.EJPS.2003.07.002

https://api.crossref.org/works/10.1016/J.EJPS.2003.07.002

27 March 2024

Identifiers

10.1016/J.EJPS.2003.07.002

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44638919&oldid=2112147509"